Protection against Progressive Leishmaniasis by IFN-β
| Autor: | Paula S. Hochman, Alexandra Wandersee-Steinhäuser, Jochen Mattner, Martin Röllinghoff, Gerard R. Majeau, Andreas Pahl, Christian Bogdan |
|---|---|
| Rok vydání: | 2004 |
| Předmět: |
Cytotoxicity
Immunologic medicine.medical_treatment Immunology Leishmaniasis Cutaneous Nitric Oxide Synthase Type II Lymphocyte proliferation Lymphocyte Activation Interferon-gamma Mice Cutaneous leishmaniasis In vivo medicine Animals Immunology and Allergy Cytotoxic T cell Leishmania major STAT1 Leishmaniasis Mice Knockout Mice Inbred BALB C Dose-Response Relationship Drug biology Interferon-beta STAT4 Transcription Factor medicine.disease biology.organism_classification Interleukin-12 DNA-Binding Proteins Killer Cells Natural Cytokine Disease Progression Trans-Activators biology.protein Leishmaniasis Visceral Nitric Oxide Synthase |
| Zdroj: | The Journal of Immunology. 172:7574-7582 |
| ISSN: | 1550-6606 0022-1767 |
| DOI: | 10.4049/jimmunol.172.12.7574 |
| Popis: | Type I IFNs (IFN-αβ) exert potent antiviral and immunoregulatory activities during viral infections, but their role in bacterial or protozoan infections is poorly understood. In this study, we demonstrate that the application of low, but not of high doses of IFN-β protects 60 or 100% of BALB/c mice from progressive cutaneous and fatal visceral disease after infection with a high (106) or low (104) number of Leishmania major parasites, respectively. IFN-β treatment of BALB/c mice restored the NK cell cytotoxic activity, increased the lymphocyte proliferation, and augmented the production of IFN-γ and IL-12 in the draining lymph node. Low, but not high doses of IFN-β caused enhanced tyrosine phosphorylation of STAT1 and STAT4, suppressed the levels of suppressor of cytokine signaling-1, and up-regulated the expression of inducible NO synthase in vivo. The IFN-β-induced increase of IFN-γ production was dependent on STAT4. Protection by IFN-β strictly required the presence of inducible NO synthase. In the absence of STAT4 or IL-12, IFN-β led to an amelioration of the cutaneous and visceral disease, but was unable to prevent its progression. These results identify IFN-β as a novel cytokine with a strong, dose-dependent protective effect against progressive cutaneous leishmaniasis that results from IL-12- and STAT4-dependent as well as -independent events. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|